NCT03726944View on ClinicalTrials.gov

The Feasibility of Delivering Consumer-based Meditation Applications to Myeloproliferative Neoplasm Patients

NACompletedINTERVENTIONAL
Enrollment

128

Participants

Timeline

Start Date

July 31, 2017

Primary Completion Date

April 2, 2018

Study Completion Date

April 2, 2018

Conditions
Myeloproliferative Neoplasm
Interventions
BEHAVIORAL

Calm App Meditation

The Calm app intervention consisted of 10 min/day of meditation for 4 weeks via the Calm smartphone app.

BEHAVIORAL

Unnamed Consumer-Based App Meditation

The unnamed consumer-based app intervention consisted of 10 min/day of meditation for 4 weeks via an unnamed consumer-based meditation smartphone app.

OTHER

Educational Control

The educational control consisted of an educational handout that was provided to participants. This control lasted for 4 weeks.

Trial Locations (1)

85004

Arizona Biomedical Collaborative, Phoenix

All Listed Sponsors
lead

Arizona State University

OTHER

NCT03726944 - The Feasibility of Delivering Consumer-based Meditation Applications to Myeloproliferative Neoplasm Patients | Biotech Hunter | Biotech Hunter